Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahar Shelly

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Mayo Clinic Proceedings|February 12, 2023
Accelerated Aging in LMNA Mutations Detected by Artificial Intelligence ECG-Derived AgeShahar Shelly, Francisco Lopez-Jimenez, Audry Chacin-Suarez, et al.
Rheumatology (Oxford, England)|March 14, 2022
Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluationShahar Shelly, Grayson Beecher, Margherita Milone, et al.
Neurology|July 3, 2023
Clinical, Neurophysiologic, and Pathologic Features in Patients With Early-Onset Postradiation NeuropathyMichael Skolka, Shahar Shelly, Marcus V Pinto, et al.
Neurology|November 5, 2024
Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment EvaluationChristopher J Klein, James D Triplett, David L Murray, et al.
Brain Communications|September 21, 2020
Expanded neuromuscular morbidity in Hodgkin lymphoma after radiotherapyTatsuya Oishi, Cory J Kogelschatz, Nathan P Young, et al.
Neurology|June 13, 2024
Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy: Correlation and PrognosticationShahar Shelly, Pannathat Soontrapa, Nicolas N Madigan, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 16, 2021
Autonomic dysfunction following COVID-19 infection: an early experienceKamal Shouman, Greg Vanichkachorn, William P Cheshire, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 25, 2026
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategiesLior Fuchs, Ifat Vigiser, Hadar Kolb, et al.
Brain Communications|December 28, 2020
Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotoniaJames D Triplett, Shahar Shelly, Guy Livne, et al.
Neurology|October 12, 2021
Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic OutcomesShahar Shelly, Christopher J Klein, P James B Dyck, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Mayo Clinic Proceedings|February 12, 2023
Accelerated Aging in LMNA Mutations Detected by Artificial Intelligence ECG-Derived AgeShahar Shelly, Francisco Lopez-Jimenez, Audry Chacin-Suarez, et al.
Rheumatology (Oxford, England)|March 14, 2022
Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluationShahar Shelly, Grayson Beecher, Margherita Milone, et al.
Neurology|July 3, 2023
Clinical, Neurophysiologic, and Pathologic Features in Patients With Early-Onset Postradiation NeuropathyMichael Skolka, Shahar Shelly, Marcus V Pinto, et al.
Neurology|November 5, 2024
Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment EvaluationChristopher J Klein, James D Triplett, David L Murray, et al.
Brain Communications|September 21, 2020
Expanded neuromuscular morbidity in Hodgkin lymphoma after radiotherapyTatsuya Oishi, Cory J Kogelschatz, Nathan P Young, et al.
Neurology|June 13, 2024
Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy: Correlation and PrognosticationShahar Shelly, Pannathat Soontrapa, Nicolas N Madigan, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 16, 2021
Autonomic dysfunction following COVID-19 infection: an early experienceKamal Shouman, Greg Vanichkachorn, William P Cheshire, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 25, 2026
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategiesLior Fuchs, Ifat Vigiser, Hadar Kolb, et al.
Brain Communications|December 28, 2020
Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotoniaJames D Triplett, Shahar Shelly, Guy Livne, et al.
Neurology|October 12, 2021
Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic OutcomesShahar Shelly, Christopher J Klein, P James B Dyck, et al.
Pageof 9